Reaction

Eosinophil Percentage Increased reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 537 reports · 8 co-occurring drugs

As of the last recalculation, Eosinophil Percentage Increased appears in 537 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is DIMENHYDRINATE (PRR 178.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Dimenhydrinate45178.6179.3
Ado-Trastuzumab Emtansine27130.6131.1
Alemtuzumab50110.4110.7
Standardized Senna Concentrate2787.587.7
Lithium Carbonate1228.028.0
Rifampicin623.223.2
Amantadine820.320.3
Daptomycin312.712.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.